Resmed (RMD)

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.

Company profile

Ticker

RMD, RSMDF

Exchange

NYSE

Website

www.resmed.com

CEO

Michael Farrell

Incorporated

Delaware

Location

California

Fiscal year end

Jun 30

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Haemonetics • Hill-Rom • Nuvasive • Integra Lifesciences ...

SEC CIK

0000943819

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

ResMed Corp. • ResMed (UK) Ltd • ResMed Asia Pacific Ltd • ResMed Beteiligungs GmbH • ResMed Holdings Pty Ltd • ResMed Pty Ltd • ResMed GmbH and Co • ResMed Motor Technologies Inc. • ResMed SAS • ResMed Paris SAS ...

IRS number

980152841

RMD stock data

1M 1Y 5Y

News

From Benzinga Pro

Competitor Recall Continues To Show Opportunities For ResMed

12 Aug 22

JP Morgan Downgrades ResMed to Neutral

12 Aug 22

JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.

Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout

12 Aug 22

Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD).

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022

12 Aug 22

RBC Capital Downgrades ResMed to Sector Perform, Raises Price Target to $252

12 Aug 22

Press releases

From Benzinga Pro

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022

11 Aug 22

Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4%Quarterly dividend increases 5% to $0.44 per share Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET

ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

3 Aug 22

Acquisition lays foundation to build ResMed's digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and

ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

2 Aug 22

ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022

14 Jul 22

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ResMed Inc.

29 Jun 22

Analyst ratings and price targets

Last 3 months

Calendar

11 Aug 22

19 Aug 22

30 Jun 23

Financial summary

Financial statements Chart RMD financial data

Quarter (USD)	Jun 22	Mar 22	Dec 21	Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 22	Jun 21	Jun 20	Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	273.71M	273.71M	273.71M	273.71M	273.71M	273.71M
Cash burn (monthly)	(no burn)	1.8M	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	3.02M	n/a	n/a	n/a	n/a
Cash remaining	n/a	270.69M	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	150.6	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Resmed earnings reports.

Recent insider trades

RMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Aug 22	Farrell Michael J.	ResMed Common Stock	Sell	Dispose S	No	Yes	238.0909	5,675	1.35M	405,260
15 Aug 22	Farrell Michael J.	ResMed Common Stock	Option exercise	Acquire M	No	Yes	57.76	5,675	327.79K	410,935
15 Aug 22	Farrell Michael J.	ResMed Common Stock Options ResMed Common Stock	Option exercise	Dispose M	No	No	57.76	5,675	327.79K	88,590
10 Aug 22	Sandercock Brett	ResMed Common Stock	Sell	Dispose S	No	Yes	240.66	2,500	601.65K	106,426
10 Aug 22	Sandercock Brett	ResMed Common Stock	Option exercise	Acquire M	No	Yes	57.76	2,500	144.4K	108,926
10 Aug 22	Sandercock Brett	ResMed Common Stock Options ResMed Common Stock	Option exercise	Dispose M	No	No	57.76	2,500	144.4K	0
3 Aug 22	David Pendarvis	ResMed Common Stock	Sell	Dispose S	No	Yes	240.72	1,545	371.91K	105,286
22 Jul 22	Sandercock Brett	ResMed Common Stock	Sell	Dispose S	No	Yes	235	7,500	1.76M	106,426
22 Jul 22	Sandercock Brett	ResMed Common Stock	Option exercise	Acquire M	No	Yes	57.76	2,500	144.4K	113,926
22 Jul 22	Sandercock Brett	ResMed Common Stock	Option exercise	Acquire M	No	Yes	57.76	2,500	144.4K	111,426

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q2 2022

RMD institutional ownership history Ownership history

13F holders	Prev Q	Change
Total holders	0
Opened positions	0
Closed positions	1	EXIT
Increased positions	0
Reduced positions	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Newegg Commerce • Itamar Medical • Inspira Technologies Oxy B.H.N.

Risks

Risks Related to Our Business and Industry
Risks Related to Manufacturing, IT Systems, Commercial Operations and Plans for Future Growth
Risks Related to Non-Compliance with Laws, Regulations and Healthcare Industry Shifts
Risks Related to the Securities Markets and Ownership of Our Common Stock

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: actigraphy, acuity, adjacent, adjournment, admission, AI, AIS, alleged, amplified, answered, appeal, artificial, backlog, Bloomington, CA, CalAmp, candidate, capture, CFC, CHEST, Cleveland, clicking, coinsurance, Colorado, complaint, conflict, constraint, cut, cyberattack, DAN, Dec, Deutschland, DIS, ease, ecosystem, emphasizing, English, enjoy, entrant, Environmental, ERS, escalation, ESG, EUDAMED, expressly, Fargo, FCPA, forty, greenhouse, guiding, Halifax, hearing, highest, HSBC, ID, inbound, inflationary, injunction, inorganic, intelligence, intelligent, ITC, IVDR, Jun, Koninklijke, Laird, LTE, malware, mandatory, manual, MDD, MEDIFOX, merchandise, military, mind, mined, Minnesota, moratorium, motion, newest, NightOwl, North, NYU, official, outpatient, paper, partly, partner, PAT, PAYGO, peace, peripheral, permissibility, philosophy, PLC, preexisting, presumption, proportion, Quectel, ransomware, rebuttable, recession, reclassified, reopen, RS, Russia, sequestration, session, situation, sought, stability, stabilizing, stakeholder, Telit, theme, thereto, threat, threaten, timeframe, trailing, UFLPA, UK, Ukraine, Unconditional, unforeseen, upfront, USA, Utah, Uyghur, VAuto, version, vertical, Virginia, visiting, wage, waiting, weather, widespread, Xinjiang, Xirgo

Removed: adjustable, affirmative, affirmatively, Annex, arrangement, assisted, autotitration, backup, bad, Birdie, bundled, CS, defending, directing, earliest, elimination, exhibiting, exit, extra, featuring, finance, forma, HCF, Holdco, hypoxemic, improper, Inova, inquiring, leak, LIBOR, Loyang, LTOT, mark, mixed, nocturnal, occurred, pro, projection, prospectively, pseudonymised, purpose, rationalization, reading, Reciprocal, regime, relocation, reorganization, resting, resupply, retained, retrospective, ruled, Shield, smaller, ST, synchrony, tentative, tick, ultimately, unaudited, upheld, ventilated, web

From filing 10-K 2022 FY

Financial reports

View all